Cargando…
Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes
More than 1,100 genetic loci have been correlated with drug response outcomes but disproportionately few have been translated into clinical practice. One explanation for the low rate of clinical implementation is that the majority of associated variants may be in linkage disequilibrium (LD) with the...
Autores principales: | Choi, Jihoon, Tantisira, Kelan G., Duan, Qing Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417988/ https://www.ncbi.nlm.nih.gov/pubmed/30214008 http://dx.doi.org/10.1038/s41397-018-0048-y |
Ejemplares similares
-
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma
por: Dahlin, Amber, et al.
Publicado: (2015) -
Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015) -
Identification of deleterious and regulatory genomic variations in known asthma loci
por: Neville, Matthew D. C., et al.
Publicado: (2018) -
Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease
por: Mulder, Daniel J., et al.
Publicado: (2020) -
Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data
por: Bertholim-Nasciben, Luciana, et al.
Publicado: (2023)